Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects

Eur J Pharmacol. 2009 Aug 15;616(1-3):43-7. doi: 10.1016/j.ejphar.2009.06.017. Epub 2009 Jun 23.

Abstract

Hypoxia and reoxygenation set in motion a series of events, including blood-brain barrier breakdown. We examined the content and effect of platelet-activating factor (PAF), which was increased in the rat brain microvessel endothelial cells (RBMECs) during hypoxia and reoxygenation. MTT method was used to assay cell damage; ELISA analysis was used to estimate PAF release after hypoxia and reoxygenation injury; and RT-PCR and Western blotting method were used to assess gene and protein expressions of inducible nitric-oxide synthase (iNOS) in RBMECs under PAF damage. PAF affected intracellular free Ca(2+) levels, increasing [Ca(2+)](i), which caused up-regulation of iNOS. We also examined the blood-brain barrier protective effect of XQ-1H, a novel ginkgolide B derivative. Pretreatment with XQ-1H (10 microM and 3 microM) for 24 h significantly antagonized PAF receptor and inhibited the increase in intracellular calcium concentration and the up-regulation of iNOS in response to PAF under hypoxia and reoxygenation in vitro.

MeSH terms

  • Animals
  • Blood-Brain Barrier / drug effects*
  • Blood-Brain Barrier / metabolism
  • Brain / blood supply
  • Calcium / metabolism
  • Cell Hypoxia
  • Cell Survival / drug effects
  • Cells, Cultured
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Ginkgolides / pharmacology*
  • Lactones / pharmacology*
  • Microvessels / cytology
  • Nitric Oxide Synthase Type II / biosynthesis
  • Nitric Oxide Synthase Type II / genetics
  • Oxygen / metabolism
  • Platelet Activating Factor / metabolism*
  • Platelet Membrane Glycoproteins / antagonists & inhibitors*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Up-Regulation / drug effects

Substances

  • Ginkgolides
  • Lactones
  • Platelet Activating Factor
  • Platelet Membrane Glycoproteins
  • RNA, Messenger
  • Receptors, G-Protein-Coupled
  • XQ-1H compound
  • platelet activating factor receptor
  • Nitric Oxide Synthase Type II
  • Oxygen
  • Calcium